IRIS Accounts Production v25.1.0.734 02705510 Board of Directors 1.8.23 31.7.24 31.7.24 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh027055102023-07-31027055102024-07-31027055102023-08-012024-07-31027055102022-07-31027055102022-08-012023-07-31027055102023-07-3102705510ns15:EnglandWales2023-08-012024-07-3102705510ns14:PoundSterling2023-08-012024-07-3102705510ns10:Director12023-08-012024-07-3102705510ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3102705510ns10:SmallEntities2023-08-012024-07-3102705510ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3102705510ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3102705510ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3102705510ns10:FullAccounts2023-08-012024-07-3102705510ns10:OrdinaryShareClass12023-08-012024-07-3102705510ns10:Director22023-08-012024-07-3102705510ns10:Director32023-08-012024-07-3102705510ns10:Director42023-08-012024-07-3102705510ns10:Director52023-08-012024-07-3102705510ns10:Director62023-08-012024-07-3102705510ns10:Director72023-08-012024-07-3102705510ns10:Director82023-08-012024-07-3102705510ns10:Director92023-08-012024-07-3102705510ns10:Director102023-08-012024-07-3102705510ns10:CompanySecretary12023-08-012024-07-3102705510ns10:RegisteredOffice2023-08-012024-07-3102705510ns5:CurrentFinancialInstruments2024-07-3102705510ns5:CurrentFinancialInstruments2023-07-3102705510ns5:Non-currentFinancialInstruments2024-07-3102705510ns5:Non-currentFinancialInstruments2023-07-3102705510ns5:ShareCapital2024-07-3102705510ns5:ShareCapital2023-07-3102705510ns5:RetainedEarningsAccumulatedLosses2024-07-3102705510ns5:RetainedEarningsAccumulatedLosses2023-07-3102705510ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3102705510ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3102705510ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-07-3102705510ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-07-3102705510ns5:Secured2024-07-3102705510ns5:Secured2023-07-3102705510ns10:OrdinaryShareClass12024-07-31
REGISTERED NUMBER: 02705510 (England and Wales)















FOSSE MEDICARE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024






FOSSE MEDICARE LIMITED (REGISTERED NUMBER: 02705510)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3 to 4


FOSSE MEDICARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTORS: Dr S A Alexander
Dr R J Britton
Dr A L Griffiths
Dr M Lewis
Dr M C Lowden
Dr P J Mahony
Dr C V Martin
Dr R A Stratton
Dr H Y Tasker
Dr N P Manning





SECRETARY: Dr M C Lowden





REGISTERED OFFICE: The Surgery
Fern Road
Cropwell Bishop
Nottinghamshire
NG12 3BU





REGISTERED NUMBER: 02705510 (England and Wales)





ACCOUNTANTS: Duncan & Toplis Limited
18 Northgate
Sleaford
Lincolnshire
NG34 7BJ

FOSSE MEDICARE LIMITED (REGISTERED NUMBER: 02705510)

STATEMENT OF FINANCIAL POSITION
31 JULY 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Investment property 4 3,352,726 3,352,726

CURRENT ASSETS
Debtors 5 66,092 57,760
Cash at bank 30,240 16,321
96,332 74,081
CREDITORS
Amounts falling due within one year 6 124,082 113,273
NET CURRENT LIABILITIES (27,750 ) (39,192 )
TOTAL ASSETS LESS CURRENT LIABILITIES 3,324,976 3,313,534

CREDITORS
Amounts falling due after more than one year 7 3,096,595 3,177,703
NET ASSETS 228,381 135,831

CAPITAL AND RESERVES
Called up share capital 9 1,300 1,300
Retained earnings 227,081 134,531
SHAREHOLDERS' FUNDS 228,381 135,831

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 28 April 2025 and were signed on its behalf by:





Dr P J Mahony - Director


FOSSE MEDICARE LIMITED (REGISTERED NUMBER: 02705510)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1. STATUTORY INFORMATION

Fosse Medicare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investment property
Investment property is shown at historic cost as the directors consider that this accurately reflects the current value of the property.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - 10 ).

4. INVESTMENT PROPERTY
Total
£   
COST
At 1 August 2023
and 31 July 2024 3,352,726
NET BOOK VALUE
At 31 July 2024 3,352,726
At 31 July 2023 3,352,726

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 7,536 57,377
Other debtors 58,556 383
66,092 57,760

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 61,787 54,951
Trade creditors - 5,440
Taxation and social security 2,754 3,348
Other creditors 59,541 49,534
124,082 113,273

FOSSE MEDICARE LIMITED (REGISTERED NUMBER: 02705510)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 2,743,173 2,804,961
Other creditors 353,422 372,742
3,096,595 3,177,703

Amounts falling due in more than five years:

Repayable otherwise than by instalments
Bank loans more 5 yrs non-inst 1,079,500 1,079,500

Repayable by instalments
Bank loans more 5 yr by instal 1,474,763 1,545,486

8. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 2,804,960 2,859,912

The bank loan is partially secured by guarantee from each director to the value of £60,000.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,300 Ordinary £1 1,300 1,300